Lab7 Systems

The company said it will use the proceeds to further develop its core software platform, and to hire additional programmers and bioinformaticians.

Their combined offering will provide customers with a single solution for managing lab operations and performing sequence analysis and mutation identification.  

Lab7 Systems has released a beta version of its next-generation sequencing data workflow management software platform, available for download to early-access users from the company's website. The company is planning updates to the software every four to six weeks.

Lab7 Systems has launched a beta version of its next-generation DNA sequence data workflow management software platform. The company is seeking feedback from beta users that will further development of its software which is expected to launch fully later this year.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.